Cargando…

Targeted Cellular Micropharmacies: Cells Engineered for Localized Drug Delivery

The recent emergence of engineered cellular therapies, such as Chimeric antigen receptor (CAR) CAR T and T cell receptor (TCR) engineered T cells, has shown great promise in the treatment of various cancers. These agents aggregate and expand exponentially at the tumor site, resulting in potent immun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gardner, Thomas J., Bourne, Christopher M., Dacek, Megan M., Kurtz, Keifer, Malviya, Manish, Peraro, Leila, Silberman, Pedro C., Vogt, Kristen C., Unti, Mildred J., Brentjens, Renier, Scheinberg, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465970/ https://www.ncbi.nlm.nih.gov/pubmed/32764348 http://dx.doi.org/10.3390/cancers12082175

Ejemplares similares

Host Interactions with Engineered T-cell Micropharmacies
por: Bourne, Christopher M., et al.
Publicado: (2023)

Host-cell Interactions of Engineered T cell Micropharmacies
por: Bourne, Christopher M., et al.
Publicado: (2023)

Autologous, lentivirus‐modified, T‐rapa cell “micropharmacies” for lysosomal storage disorders
por: Nagree, Murtaza S, et al.
Publicado: (2022)

CAR Chase: Where Do Engineered Cells Go in Humans?
por: Krebs, Simone, et al.
Publicado: (2020)

Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications
por: Kurtz, Keifer, et al.
Publicado: (2023)

Engineering strategies to overcome the current roadblocks in CAR T cell therapy
por: Rafiq, Sarwish, et al.
Publicado: (2019)

Dual targeting ovarian cancer by Muc16 CAR-T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1
por: Mun, Sung Soo, et al.
Publicado: (2023)

CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process
por: Altvater, Bianca, et al.
Publicado: (2023)

Multipurposing CARs: Same engine, different vehicles
por: Hossian, A.K.M. Nawshad, et al.
Publicado: (2022)

Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen
por: Rafiq, S, et al.
Publicado: (2016)

How do CARs work?: Early insights from recent clinical studies targeting CD19
por: Davila, Marco L., et al.
Publicado: (2012)

Toxicity and management in CAR T-cell therapy
por: Bonifant, Challice L, et al.
Publicado: (2016)

Acute myeloid leukemia arising from a donor derived premalignant hematopoietic clone: A possible mechanism for the origin of leukemia in donor cells
por: Dickson, Mark A., et al.
Publicado: (2014)

A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16(ecto) directed chimeric antigen receptors for recurrent ovarian cancer
por: Koneru, Mythili, et al.
Publicado: (2015)

Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment
por: Yeku, Oladapo O., et al.
Publicado: (2017)

Cytokine IL-36γ Improves CAR T Cell Functionality and Induces Endogenous Anti-Tumor Response
por: Li, Xinghuo, et al.
Publicado: (2020)

Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System
por: Avanzi, Mauro P., et al.
Publicado: (2018)

CD103(+) cDC1 and endogenous CD8(+) T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function
por: Kuhn, Nicholas F., et al.
Publicado: (2020)

Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Chimeric Antigen Receptor T Cells
por: Park, Jae H, et al.
Publicado: (2018)

Modeling anti-CD19 CAR T cell therapy in humanized mice with human immunity and autologous leukemia
por: Jin, Chun-Hui, et al.
Publicado: (2018)

Calculations for engineering economic analysis
por: Kurtz, Max
Publicado: (1995)

Engineering the Cellular Microenvironment of Post-infarct Myocardium on a Chip
por: Khalil, Natalie N., et al.
Publicado: (2021)

IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models
por: Jaspers, Janneke E., et al.
Publicado: (2023)

Handbook of applied mathematics for engineers and scientists
por: Kurtz, Max
Publicado: (1991)

Modeling Signal Transduction in Classical Conditioning with Network Motifs
por: Keifer, Joyce, et al.
Publicado: (2011)

A catechism of the steam engine : in its various applications to mines, mills, steam navigation, railways, and agriculture: with practical instructions for the manufacture and management of engines of every class
por: Bourne, John
Publicado: (1876)

Correlation of IL-6 secretion and hyponatremia with the use of CD19+ chimeric antigen receptor T-cells
por: Dixon, Brianne N., et al.
Publicado: (2020)

The “Great Debate” at Immunotherapy Bridge 2022, Naples, November 30th–December 1st, 2022
por: Ascierto, Paolo A., et al.
Publicado: (2023)

Primetime for Learning Genes
por: Keifer, Joyce
Publicado: (2017)

Single-molecule sensing of peptides and nucleic acids by engineered aerolysin nanopores
por: Cao, Chan, et al.
Publicado: (2019)

Ancestral Background Is Underreported in Regenerative Engineering
por: Ryan, Holly, et al.
Publicado: (2021)

Critical care rotation impact on pediatric resident mental health and burnout
por: Wolfe, Katie K., et al.
Publicado: (2017)

Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition
por: Yeku, Oladapo O., et al.
Publicado: (2021)

Engineering Cellular Photocomposite Materials Using Convective Assembly
por: Jenkins, Jessica S., et al.
Publicado: (2013)

Restructuring the Cellular Responses: Connecting Microbial Intervention With Ecological Fitness and Adaptiveness to the Maize (Zea mays L.) Grown in Saline–Sodic Soil
por: Singh, Shailendra, et al.
Publicado: (2021)

Proceedings From the First International Workshop at Sidra Medicine: “Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development”, 15(th)–16(th) February 2019, Doha, Qatar
por: Guerrouahen, Bella, et al.
Publicado: (2021)

Engineering and monitoring cellular barrier models
por: Yeste, Jose, et al.
Publicado: (2018)

Far From the Biliary Tree: A Case of Overlapping Autoimmune Liver Disease in a Patient Presenting With Sicca Symptoms
por: Walsh, Keifer, et al.
Publicado: (2022)

Microbial Consortia Engineering for Cellular Factories: in vitro to in silico systems
por: Bernstein, Hans C, et al.
Publicado: (2012)

Nucleosome occupancy reveals regulatory elements of the CFTR promoter
por: Ott, Christopher J., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7mub1i4n3fmbu6d7c3ei9vuqi4